Cite Filings / ALDX / 0000950170-25-051722

Feed Companies Filings Check

Sign in

SCHEDULE 13G/A

Statement of Beneficial Ownership

Aldeyra Therapeutics, Inc. Filed 2025-04-07 Acc 0000950170-25-051722

Documents 1

SCHEDULE 13G/A Statement of Beneficial Ownership , xslSCHEDULE_13G_X01/primary_doc.xml

Around this filing

2025-08-14 SCHEDULE 13G/A Statement of Beneficial Ownership
2025-04-07 4 10% owner sold 3,400,000 shares at $1.42 ($4,828,000)
2025-04-07 SCHEDULE 13G/A Statement of Beneficial Ownership
2025-04-03 8-K Regulation FD disclosure · Other events

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)

Loading xslSCHEDULE_13G_X01/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…